VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH MM 2018 | Real world data: bortezomib-based therapy for R/R myeloma

Evangelos Terpos, MD, PhD, of the University of Athens, Athens, Greece, discusses real world data on the use of bortezomib for relapsed/refractory multiple myeloma (MM). Dr Terpos highlights the importance of these results, particularly in cases where newer drugs are not available. This interview was recorded at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter